Selective Laser Trabeculoplasty
- PMID: 37755442
- PMCID: PMC10662953
- DOI: 10.1097/IIO.0000000000000483
Selective Laser Trabeculoplasty
Abstract
Selective laser trabeculoplasty (SLT) is a common ophthalmic procedure used to lower intraocular pressure. The mechanism of SLT action remains controversial but may involve the upregulation of protein expressions in the trabecular meshwork that increases outflow facility. Several prospective trials have demonstrated the safety and efficacy of SLT as both adjunctive and primary glaucoma therapy, and the utilization of SLT in stable, medically-controlled glaucoma patients may decrease medication burden and potentially improve the patients’ quality of life.
Conflict of interest statement
The authors declare that they have no conflicts of interest to disclose.
References
-
- Arora KS, Robin AL, Corcoran KJ, et al., Use of Various Glaucoma Surgeries and Procedures in Medicare Beneficiaries from 1994 to 2012. Ophthalmology, 2015. 122(8): p. 1615–24. - PubMed
-
- Latina MA, Sibayan SA, Shin DH, et al., Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study. Ophthalmology, 1998. 105(11): p. 2082–8; discussion 2089–90. - PubMed
-
- Melamed S, Ben Simon GJ, and Levkovitch-Verbin H, Selective laser trabeculoplasty as primary treatment for open-angle glaucoma: a prospective, nonrandomized pilot study. Arch Ophthalmol, 2003. 121(7): p. 957–60. - PubMed
-
- Odberg T and Sandvik L, The medium and long-term efficacy of primary argon laser trabeculoplasty in avoiding topical medication in open angle glaucoma. Acta Ophthalmol Scand, 1999. 77(2): p. 176–81. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources